Retinal Nerve Fiber Layer Thickness Analysis With Cirrus HD OCT Versus Stratus Optical Coherence Tomography (OCT)
Launched by YONSEI UNIVERSITY · Oct 3, 2008
Trial Information
Current as of May 11, 2025
Unknown status
Keywords
ClinConnect Summary
The Cirrus HD OCT is a new spectral domain OCT. Even though its resolution and speed are much better than the previous time domain Stratus OCT, its diagnostic power for glaucoma detection and judgement of disease progression should be directly compared with Stratus OCT. In the present study, we will review the data of peripapillary retinal nerve fiber layer thickness measurement using the Cirrus HD OCT and Stratus OCT. Their discriminating ability for diagnosis of glaucoma and judgement of disease progression will be compared using the ROC curves and Cohen's kappa.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Retinal nerve fiber layer analysis with Cirrus OCT and Stratus OCT within 1 month
- Exclusion Criteria:
- • Intraocular surgeries history
- • DM
- • High refractive error ( \< -4.00 diopters, or \> + 4.00 diopters)
- • Media opacity
About Yonsei University
Yonsei University, a prestigious institution located in South Korea, is renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, Yonsei University leverages its extensive expertise and innovative approaches in various fields of medicine to conduct rigorous clinical trials aimed at improving patient outcomes and advancing healthcare solutions. The university's robust infrastructure, multidisciplinary collaboration, and adherence to ethical standards ensure the integrity and reliability of its research initiatives, making it a key player in the global clinical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seoul, , Korea, Republic Of
Patients applied
Trial Officials
Gong Je Seong, MD, PhD
Study Chair
Yonsei University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials